# NKGen Biotech shares surged 80% in premarket trading after Co. announced phase I trial data on the use of its investigational NK cell therapy, SNK01.
**Penny Stocks News**

**2023-10-27 09:09**

**https://www.ainvest.com/news/nkgen-biotech-shares-surged-80-in-premarket-trading-after-co-announced-phase-i-trial-data-on-use-of-its-investigational-nk-cell-therapy-snk01-231010002a562e1a43697dbb/**

NKGen Biotech shares surged 80% in premarket trading after Co. announced phase I trial data on the use of its investigational NK cell therapy, SNK01.